Title |
Emery–Dreifuss muscular dystrophy: a test case for precision medicine
|
---|---|
Published in |
The Application of Clinical Genetics, February 2016
|
DOI | 10.2147/tacg.s75028 |
Pubmed ID | |
Authors |
De-Ann M Pillers, Nicholas H Von Bergen |
Abstract |
Emery-Dreifuss muscular dystrophy (EDMD) is characterized by the clinical triad of scapulohumeroperoneal muscle weakness, joint contractures, and cardiac defects that include arrhythmias and dilated cardiomyopathy. Although there is a defining group of clinical findings, the proteins responsible and their underlying gene defects leading to EDMD are varied. A common aspect of the gene defects is their involvement in, or with, the nuclear envelope. Treatment approaches are largely based on clinical symptoms. The genetic diversity of EDMD predicts that a cure will ultimately depend upon the individual's defect at the gene level, making this an ideal candidate for a precision medicine approach. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 47 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 9 | 19% |
Student > Master | 7 | 15% |
Student > Bachelor | 5 | 11% |
Researcher | 4 | 9% |
Professor | 4 | 9% |
Other | 6 | 13% |
Unknown | 12 | 26% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 12 | 26% |
Biochemistry, Genetics and Molecular Biology | 11 | 23% |
Agricultural and Biological Sciences | 4 | 9% |
Computer Science | 3 | 6% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 4% |
Other | 0 | 0% |
Unknown | 15 | 32% |